Teva Pharmaceutical Industries stock has drawn renewed attention after consensus analyst price targets edged higher, rising ...

Wondering if Teva Pharmaceutical Industries is now a bargain or if you might be late to the party? You're not alone.

Teva Pharmaceutical Industries Ltd ADR has reached a significant milestone, with its stock hitting a 52-week high of 26.38 USD, with the current price of 26.37 USD sitting just 0.99% below this peak.

What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Monday outlined that Weiss executed a sale of 12,300 shares of Teva Pharmaceutical Indus with a total value of ...

Teva Pharmaceutical Industries Ltd ADR has reached a significant milestone as its stock hit a 52-week high, trading at $25.96. This achievement marks a notable recovery and growth trajectory for the ...

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 12.9% in a month. Teva’s stock mainly gained after it announced first-quarter 2025 results on May 7. Teva’s first-quarter results were ...

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and Biolojic Design Ltd announced that Teva initiated IND-enabling studies with BD9, a dual-specific multibody targeting both TSLP (Thymic stromal ...

CMS’ newly released maximum fair prices include list-price reductions of 38% to 85% for 15 widely used medicines beginning in ...

Teva Pharmaceutical Industries Limited’s TEVA shares have risen 19.4% in the past month. A key driver of the stock price increase was its mixed second-quarter results announced on July 30. Teva’s ...